RA Capital Management’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,622,574
Closed -$9.98M 98
2022
Q2
$9.98M Sell
4,622,574
-3,032,441
-40% -$10.3M 0.27% 58
2022
Q1
$28.4M Hold
7,655,015
0.62% 48
2021
Q4
$47.2M Buy
+7,655,015
New +$87.4M 0.83% 34

Other funds holding LIAN

RA Capital Management's LIAN Position: Q3 2022 in Review

RA Capital Management sold out of LianBio American Depositary Shares (LIAN) in Q3 2022, closing a stake of 4,622,574 shares — an estimated $9.98M sold.

RA Capital Management first reported a position in LIAN in Q4 2021 and held it in 3 quarters. The position peaked at $47.2M in Q4 2021. 44 funds tracked by Wall St. Rank hold LIAN as of Q3 2022.

  • RA Capital Management reported no remaining LianBio American Depositary Shares position as of Q3 2022 after selling out during the quarter.
  • RA Capital Management sold 4,622,574 LianBio American Depositary Shares shares in Q3 2022, an estimated $9.98M.
  • RA Capital Management first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • RA Capital Management's LianBio American Depositary Shares position peaked at $47.2M in Q4 2021.
  • 44 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q3 2022.

Based on RA Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.